Safety and Performance of BonyPid-1000™ in the Treatment of Gustilo I, II, IIIA and IIIB Tibial Open Fractures
Sponsor: PolyPid Ltd.
This NA trial investigates Open Fractures and Tibial Fractures and is currently completed. PolyPid Ltd. leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2020 — Sep 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2018 — Jun 2020 [monthly]
Active Not Recruiting NA
Phase: PHASE2 → NA
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting · Phase: NA → PHASE2
-
Jan 2017 — May 2018 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- PolyPid Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .